Sensei Biotherapeutics Inc (SNSE) stock is lower by -85.27% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives SNSE stock a score of 35 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 3. SNSE's rank also includes a long-term technical score of 5. SNSE has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on SNSE!